CLPT

Clearpoint Neuro Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 2/10
  • Value↓ 0/10
Clearpoint Neuro sales and earnings growth
CLPT Growth
Fair
  • Revenue Y/Y↑ 17.78%
  • EPS Y/Y↓ -28.57%
  • FCF Y/Y↓ -165.01%
Clearpoint Neuro gross and profit margin trends
CLPT Profitability
Neutral
  • Gross margin ↑ 61.40%
  • EPS margin↓ -69.10%
  • ROIC 5Y↓ -85.69%
Clearpoint Neuro net debt vs free cash flow
CLPT Risk
Fair
  • Debt / Equity↑ 2.1
  • Debt / FCF↓ 0.5
  • Interest coverage↓ -9.7

Clearpoint Neuro stock volatility is higher than the overall market. We give it a Fair risk rating.

More Medical Devices stocks ↗